FDA Logo--links to FDA home page
U.S. Food and Drug Administration
HHS Log--links to Department of Health and Human Services website
FDA Home Page | About Medwatch | Contact MedWatch | MedWatch Partners
 MedWatch logoThe FDA Safety Information and Adverse Event Reporting Program


 
 

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- January 2003

 

The detailed view includes drug products with safety labeling changes to the CONTRAINDICATIONS, BOXED WARNING, WARNINGS, PRECAUTIONS, or ADVERSE REACTIONS sections. The prescribing information may be accessed by clicking on the drug name.

Summary View

 

Brand (Generic) Name

Sections Modified

Summary of Changes to Contraindications and Warnings

Premarin (conjugated estrogen tablets, USP)

(click product name to read label)

CONTRAINDICATIONS

BOXED WARNING

  • Cardiovascular and Other Risks

WARNINGS

  • Cardiovascular disorders
    • Coronary heart disease and stroke
    • Venous thromboembolism (VTE)
  • Malignant neoplasm
    • Breast cancer
  • Visual abnormalities

PRECAUTIONS

  • General
    • Addition of a progestin when a woman has not had a hysterectomy
    • Elevated blood pressure
    • Ovarian Cancer
  • Patient Information
  • Laboratory Tests
  • Pregnancy
  • Nursing Mothers
  • Geriatric Use

ADVERSE REACTIONS

  • Genitourinary system
  • Breasts
  • Cardiovascular
  • Eyes
  • Central Nervous System
  • Miscellaneous

PATIENT INFORMATION

Estrogens with or without progestins should not be used for the prevention of cardiovascular disease. The Women's Health Initiative (WHI) reported increased risks of myocardial infarction, stroke, invasive breast cancer, pulmonary emboli, and deep vein thrombosis in postmenopausal women during 5 years of treatment with conjugated equine estrogens (0.625 mg) combined with medroxyprogesterone acetate (2.5 mg) relative to placebo.

Thalomid (thalidomide) Capsules

(click product name to read label)

CONTRAINDICATIONS

  • Pregnancy: Category X
BOXED WARNING
  • Prescribers
  • Female Patients
  • Male Patients

PRECAUTIONS

  • Laboratory Tests
    • Pregnancy Testing
    • Increased HIV Viral Load
  • Carcinogenesis, Mutagenesis, Impairment of Fertility
  • Pregnancy

ADVERSE REACTIONS

  • Other Adverse Events Observed in ENL Patients
    • Cardiovascular System
    • Nervous System

IMPORTANT INFORMATION AND WARNINGS FOR ALL PATIENTS

Revisions to the boxed warnings containing special information for prescribers, female patients, and male patients about procedures that must be followed to prevent fetal exposure.

Toprol-XL (metoprolol succinate) Extended Release Tablets

(click product name to read label)

CONTRAINDICATIONS

WARNINGS

  • Peripheral Vascular Disease
  • Calcium Channel Blockers

PRECAUTIONS

  • General
  • Drug Interactions

ADVERSE REACTIONS

  • Hypertension and Angina
  • Postmarketing Experience

Peripheral Vascular Disease: Beta-blockers can precipitate or aggravate symptoms of arterial insufficiency in patients with peripheral vascular disease. Caution should be exercised in such individuals.

Calcium Channel Blockers: Because of significant inotropic and chronotropic effects in patients treated with beta-blockers and calcium channel blockers of the verapamil and diltiazem type, caution should be exercised in patients treated with these agents concomitantly.

MedWatch Home | Safety Information | Submit Report | How to Report | Download Forms | Join the E-list | Comments

Back to Summary Page

Brand (Generic) Name

Sections Modified

Summary of Changes to Contraindications and Warnings

Novantrone (mitoxantrone) for Injection Concentrate

(click product name to read label)

BOXED WARNING 

WARNINGS

  • General
  • Secondary Leukemia

PRECAUTIONS

  • Geriatric Use
    • Multiple Sclerosis
    • Hormone-Refractory Prostate Cancer
    • Acute Nonlymphocytic Leukemia

Secondary acute myelogenous leukemia (AML) has been reported in cancer patients treated with anthracyclines. NOVANTRONE is an anthracenedione, a related drug. Secondary AML has also been reported in cancer patients and multiple sclerosis patients who have been treated with NOVANTRONE.

Prempro /Premphase (conjugated estrogens/medroxyprogesterone acetate tablets)

(click product name to read label)

BOXED WARNING

WARNINGS

  • Cardiovascular Disorders
  • Malignant Neoplasms
    • Breast Cancer

See summary for Premarin [above]

Rapamune (sirolimus) Oral Solution

Rapamune (sirolimus) Tablets

(click product name to read label)

BOXED WARNING

WARNINGS

PRECAUTIONS

  • General
  • Other Drug Interactions
  • Herbal Preparations

ADVERSE REACTIONS

  • Other Clinical Experience

Increased susceptibility to infection and the possible development of lymphoma may result from immunosuppression.

Liver Transplantation – Excess Mortality, Graft Loss, and Hepatic Artery Thrombosis (HAT): The use of sirolimus in combination with tacrolimus was associated with excess mortality and graft loss in a study in de novo liver transplant recipients.

MedWatch Home | Safety Information | Submit Report | How to Report | Download Forms | Join the E-list | Comments

Back to Summary Page

Brand (Generic) Name

Sections Modified

Summary of Changes to Contraindications and Warnings

Atacand (candesartan cilexetil) Tablets

(click product name to read label)

WARNINGS

  • Fetal/Neonatal Morbidity and Mortality

PRECAUTIONS

  • General
    • Drug Interactions
      • Lithium
Post marketing experience has identified reports of fetal and neonatal toxicity in babies born to women treated with ATACAND during pregnancy.

Gemzar (gemcitabine HCl) for Injection

(click product name to read label)

WARNINGS
  • Hematology
  • Pulmonary
  • Renal
  • Hepatic

PRECAUTIONS

  • Drug Interactions

ADVERSE REACTIONS

  • Single Agent Use
  • Combination Use in Non-Small Lung Cancer
  • Post-marketing experience
    • Cardiovascular
    • Vascular Disorders
    • Skin
    • Hepatic
    • Pulmonary
    • Renal

The previous Hemolytic-Uremic Syndrome [HUS] section has been repolaced with a new Hematology, Pulmonary, Renal, and Hepatic section.

Lopid (gemfibrozil) Tablets

(click product name to read label)

WARNINGS

ADVERSE REACTIONS

Cases of cholelithiasis have been reported with gemfibrozil therapy.

MedWatch Home | Safety Information | Submit Report | How to Report | Download Forms | Join the E-list | Comments

Back to Summary Page

Brand (Generic) Name

Sections Modified

5% Dextrose and Potassium Chloride Injection, USP in Viaflex Plus Container

Please contact Baxter Healthcare at 1-800-422-9837 for product information.

PRECAUTIONS
  • Carcinogenesis, Mutagenesis, Impairment of Fertility
  • Nursing Mothers
  • Pediatric Use

Actos (pioglitazone hydrochloride) Tablets

(click product name to read label)

PRECAUTIONS
  • Drug Interactions
    • Oral Contraceptives

Busulfex (busulfan) Injection

(click product name to read label)

PRECAUTIONS
  • Special Populations
    • Pediatric

Covera-HS (verapamil hydrochloride) Extended-Release Tablets, Controlled-Onset

(click product name to read label)

PRECAUTIONS
  • General
    • Use in Patients with Attenuated [decreased] Neuromuscular Transmission
  • Drug Interactions
    • Cytochrome inducers/inhibitors
    • Aspirin
    • Grapefruit juice
  • Drug-Drug Interactions
    • Effects of Other Drugs on Verapamil Pharmacokinetics
    • Aspirin
    • Grapefruit
  • Geriatric Use

ADVERSE REACTIONS

  • Nervous System

Dobutamine Hydrochloride in 5% Dextrose Injection, USP in Plastic Container

PRECAUTIONS
  • Geriatric Use

Effexor (venlafaxine hydrochloride) Immediate Release Tablets

(click product name to read label)

PRECAUTIONS
  • General
    • Changes in Appetite and Weight
    • Hyponatremia
    • Abnormal Bleeding
    • Use in Patients with Concomitant Illness
  • Carcinogenesis, Mutagenesis, and Impairment of Fertility
  • Pregnancy
    • Non-teratogenic Effects
  • Information for Patients
    • Concomitant Medications

ADVERSE REACTIONS

  • Adverse Findings Observed in Short-Term, Placebo-Controlled Studies
    • Laboratory Changes
  • Incidence in Controlled Trials
    • Vital Sign Changes
    • ECG Changes
  • Postmarketing Reports

Effexor XR (venlafaxine hydrochloride) Extended Release Capsules

(click product name to read label)

PRECAUTIONS
  • General
    • Changes in Appetite and Weight
    • Hyponatremia
    • Abnormal Bleeding
    • Use in Patients with Concomitant Illness
  • Carcinogenesis, Mutagenesis, and Impairment of Fertility
  • Pregnancy
    • Non-teratogenic Effects
  • Information for Patients
    • Concomitant Medications

ADVERSE REACTIONS

  • Adverse Findings Observed in Short-Term, Placebo-Controlled Studies
    • Laboratory Changes
  • Incidence in Controlled Trials
    • Vital Sign Changes
    • ECG Changes
  • Postmarketing Reports

Emla Cream (lidocaine 2.5% and prilocaine 2.5%)
Emla Anesthetic Disc (lidocaine 2.5% and prilocaine 2.5% cream) Topical Adhesive System

(click product name to read label)

PRECAUTIONS

  • Carcinogenesis, Mutagenesis, Impairment of Fertility

ADVERSE REACTIONS

  • Localized Reactions

Feldene (piroxicam) Capsules

(click product name to read label)

PRECAUTIONS
  • Geriatric Use

Femara (letrozole) Tablets

(click product name to read label)

PRECAUTIONS
  • Geriatric Use

Imdur (isosorbide mononitrate) Extended Release Tablets

(click product name to read label)

PRECAUTIONS
  • Geriatric Use

Larium (mefloquine hydrochloride) Tablets

(click product name to read label)

PRECAUTIONS
  • General
  • Information for Patients
  • Drug Interactions
  • Carcinogenesis, Mutagenesis, Impairment of Fertility
  • Pregnancy
    • Teratogenic Effects
  • Nursing Mothers
  • Geriatric Use
Lithium Carbonate Tablets, USP
Lithium Carbonate Capsules, USP
Lithium Citrate Syrup, USP

(click product name to read label)

PRECAUTIONS
  • Drug Interactions

Megace (megestrol acetate tablets, USP)

(click product name to read label)

PRECAUTIONS
  • Geriatric Use
Methotrexate Sodium for Injection

Methotrexate for Injection

Please contact Wyeth-Ayerst Laboratories at 1-800-999-9384 for product information.

PRECAUTIONS
  • Geriatric Use

ADVERSE REACTIONS

  • Organ System Toxicity
    • Hematologic
    • Pulmonary
    • Renal
    • Blood and Lymphatic System Disorders
    • Hepatobiliary Disorders
    • Infection

Nolvadex (tamoxifen citrate) Tablets

(click product name to read label)

PRECAUTIONS
  • Pediatric Use

ADVERSE REACTIONS

  • Pediatric Patients McCune-Albright Syndrome

PATIENT INFORMATION SHEET

  • Who Should Not Take Nolvadex?

Potassium Chloride in 5% Dextrose and Lactated Ringer's Injection, USP in Plastic Container

Please contact Baxter Healthcare at 1-800-422-9837 for product information.

PRECAUTIONS
  • Carcinogenesis, Mutagenesis, Impairment of Fertility
  • Nursing Mothers
  • Pediatric Use

Pulmicort Respules (budesonide inhalation suspension)

(click product name to read label)

PRECAUTIONS
  • Carcinogenesis, Mutagenesis, Impairment of Fertility
  • Pregnancy
    • Teratogenic Effects
Stromectol (ivermectin) Tablets PRECAUTIONS
  • General

Sustiva (efavirenz) Capsules

(click product name to read label)

PRECAUTIONS
  • General
  • Carcinogenesis, Mutagenesis, Impairment of Fertility
  • Patient Information
Tenormin (atenolol) Tablets

Tenormin (atenolol) I.V. Injection

(click product name to read label)

PRECAUTIONS
  • Geriatric Use

Timolide (timolol maleate - hydrochlorothiazide) Tablets

(click product name to read label)

PRECAUTIONS
  • Geriatric Use

Travatan (travoprost ophthalmic solution) Sterile

(click product name to read label)

PRECAUTIONS

  • General
  • Carcinogenesis, Mutagenesis, Impairment of Fertility
  • Pregnancy
    • Teratogenic Effects

Zanosar (streptozocin sterile powder)

(click product name to read label)

PRECAUTIONS
  • Geriatric Use

Ziac (bisoprolol fumarate and hydrochlorthiazide) Tablets

(click product name to read label)

PRECAUTIONS
  • Bisoprolol Furmarate

ADVERSE REACTIONS

  • Bisoprolol Fumarate
    • Central Nervous System
    • Cardiovascular
    • Gastrointestinal
    • Musculoskeletal
    • Respiratory
    • Genito-urinary
    • General

MedWatch Home | Safety Information | Submit Report | How to Report | Download Forms | Join the E-list | Comments

Back to Summary Page

Brand (Generic) Name

Sections Modified

Mesnex (mesna) Injection and Tablets

(click product name to read label)

ADVERSE REACTIONS

PATIENT PACKAGE INSERT [Tablets Only]

Oxilan (ioxilan injection) ADVERSE REACTIONS

Purinethol (mercaptopurine) Tablets

(click product name to read label)

ADVERSE REACTIONS
  • Miscellaneous

Taxotere (docetaxel) for Injection Concentrate

(click product name to read label)

ADVERSE REACTIONS
  • Postmarketing Experience
    • Cutaneous
    • Gastrointestional
    • Hematologic
    • Hepatic
    • Neurologic
    • Ophthalmologic

Zebeta (bisoprol fumarate) Tablets

(click product name to read label)

ADVERSE REACTIONS
  • Central Nervous System
  • Gastrointestinal
  • Musculoskeletal
  • Skin
  • Special Senses
  • Genitourinary
  • General

Back to Summary Page